Allogeneic haematopoietic stem cell transplantation: individualized stem cell and immune therapy of cancer. (Q48881552)

16 February 2018

review article

1 reference

title

Allogeneic haematopoietic stem cell transplantation: individualized stem cell and immune therapy of cancer. (English)

1 reference

16 February 2018

stem cell transplantation

1 reference

1 reference

Robert R Jenq

1

1 reference

16 February 2018

Marcel R M van den Brink

series ordinal

2

1 reference

16 February 2018

language of work or name

English

0 references

publication date

19 February 2010

1 reference

16 February 2018

published in

Nature Reviews Cancer

1 reference

16 February 2018

volume

10

1 reference

16 February 2018

page(s)

213-221

1 reference

16 February 2018

issue

3

1 reference

16 February 2018

https://scigraph.springernature.com/pub.10.1038/nrc2804

exact match

0 references

cites work

Identical-twin bone marrow transplants for leukemia.

1 reference

DNA immunization against tissue-restricted antigens enhances tumor immunity after allogeneic hemopoietic stem cell transplantation.

21 January 2018

1 reference

Preterminal host dendritic cells in irradiated mice prime CD8+ T cell-mediated acute graft-versus-host disease

21 January 2018

1 reference

Haematopoietic stem cell transplantation: can our genes predict clinical outcome?

21 January 2018

1 reference

Reexposure of cord blood to noninherited maternal HLA antigens improves transplant outcome in hematological malignancies

21 January 2018

1 reference

Graft-versus-leukemia effects of transplantation and donor lymphocytes

21 January 2018

1 reference

Hematopoietic-cell transplantation at 50.

31 March 2020

1 reference

Intravenous infusion of bone marrow in patients receiving radiation and chemotherapy

31 March 2020

1 reference

Supralethal whole body irradiation and isologous marrow transplantation in man.

31 March 2020

1 reference

Antigen CD34+ marrow cells engraft lethally irradiated baboons

31 March 2020

1 reference

Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers

31 March 2020

1 reference

A randomized multicenter comparison of bone marrow and peripheral blood in recipients of matched sibling allogeneic transplants for myeloid malignancies.

31 March 2020

1 reference

Acute and chronic graft-versus-host disease after allogeneic peripheral-blood stem-cell and bone marrow transplantation: a meta-analysis

31 March 2020

1 reference

Higher mortality after allogeneic peripheral-blood transplantation compared with bone marrow in children and adolescents: the Histocompatibility and Alternate Stem Cell Source Working Committee of the International Bone Marrow Transplant Registry

31 March 2020

1 reference

Hematopoietic stem cells are uniquely selective in their migratory response to chemokines

31 March 2020

1 reference

CXCR4 antagonists: targeting the microenvironment in leukemia and other cancers

31 March 2020

1 reference

Hematopoietic reconstitution in a patient with Fanconi's anemia by means of umbilical-cord blood from an HLA-identical sibling

31 March 2020

1 reference

Phenotypic analysis of functional T-lymphocyte subtypes and natural killer cells in human cord blood: relevance to umbilical cord blood transplantation

31 March 2020

1 reference

Cord blood CD4(+)CD25(+)-derived T regulatory cell lines express FoxP3 protein and manifest potent suppressor function

31 March 2020

1 reference

Assessment of optimal size and composition of the U.S. National Registry of hematopoietic stem cell donors.

31 March 2020

1 reference

31 March 2020

1 reference

Creation of a double chimera after the transplantation of umbilical-cord blood from two partially matched unrelated donors

31 March 2020

1 reference

Transplantation of 2 partially HLA-matched umbilical cord blood units to enhance engraftment in adults with hematologic malignancy

31 March 2020

1 reference

Rapid and complete donor chimerism in adult recipients of unrelated donor umbilical cord blood transplantation after reduced-intensity conditioning

31 March 2020

1 reference

Umbilical cord blood transplantation after nonmyeloablative conditioning: impact on transplantation outcomes in 110 adults with hematologic disease

31 March 2020

1 reference

Mimicking stem cell niches to increase stem cell expansion

31 March 2020

1 reference

Dose-dependent effects of the Notch ligand Delta1 on ex vivo differentiation and in vivo marrow repopulating ability of cord blood cells

31 March 2020

1 reference

Extended in vitro expansion of adult, mobilized CD34+ cells without significant cell senescence using a stromal cell coculture system with single cytokine support

31 March 2020

1 reference

Expansion of human hematopoietic stem cells for transplantation: trends and perspectives.

31 March 2020

1 reference

Expansion of hematopoietic stem/progenitor cells

31 March 2020

1 reference

Forward RNAi screens in primary human hematopoietic stem/progenitor cells

31 March 2020

1 reference

Treatment of murine leukaemia with X rays and homologous bone marrow; preliminary communication.

31 March 2020

1 reference

Lethal graft-versus-host disease after bone marrow transplantation across minor histocompatibility barriers in mice. Prevention by removing mature T cells from marrow

31 March 2020

1 reference

Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants

31 March 2020

1 reference

Graft-versus-host disease

31 March 2020

1 reference

Antileukemic Effect of Graft-versus-Host Disease in Human Recipients of Allogeneic-Marrow Grafts

31 March 2020

1 reference

Graft-versus-leukemia effects in T lineage and B lineage acute lymphoblastic leukemia.

31 March 2020

1 reference

Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation

31 March 2020

1 reference

Mixed chimerism and permanent specific transplantation tolerance induced by a nonlethal preparative regimen

31 March 2020

1 reference

Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects

31 March 2020

1 reference

Graft-versus-tumor effects after allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning

31 March 2020

1 reference

Reduced intensity conditioning for allogeneic hematopoietic cell transplantation: current perspectives

31 March 2020

1 reference

Twenty years of unrelated donor hematopoietic cell transplantation for adult recipients facilitated by the National Marrow Donor Program

31 March 2020

1 reference

Hematopoietic stem cell transplantation from alternative donors for high-risk acute leukemia: the haploidentical option

31 March 2020

1 reference

Hematopoietic SCT from partially HLA-mismatched (HLA-haploidentical) related donors

31 March 2020

1 reference

Shared biology of GVHD and GVT effects: potential methods of separation

31 March 2020

1 reference

Regulating regulatory T cells

31 March 2020

1 reference

Separation of graft-vs.-tumor effects from graft-vs.-host disease in allogeneic hematopoietic cell transplantation

31 March 2020

1 reference

Immunobiology of allogeneic hematopoietic stem cell transplantation

31 March 2020

1 reference

Immunomodulation in the treatment of haematological malignancies

31 March 2020

1 reference

Generation of tumor-specific T-cell therapies

31 March 2020

1 reference

Host natural killer T cells induce an interleukin-4-dependent expansion of donor CD4+CD25+Foxp3+ T regulatory cells that protects against graft-versus-host disease

31 March 2020

1 reference

Natural killer cell alloreactivity and haplo-identical hematopoietic transplantation

31 March 2020

1 reference

Infusion of haplo-identical killer immunoglobulin-like receptor ligand mismatched NK cells for relapsed myeloma in the setting of autologous stem cell transplantation

31 March 2020

1 reference

Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer

31 March 2020

1 reference

Targets of tumor immunity after allogeneic hematopoietic stem cell transplantation

31 March 2020

1 reference

Characterizing and optimizing immune responses to leukaemia antigens after allogeneic stem cell transplantation

31 March 2020

1 reference

Leukemia-associated antigens are critical for the proliferation of acute myeloid leukemia cells

31 March 2020

1 reference

Adoptive transfer of virus-specific and tumor-specific T cell immunity

31 March 2020

1 reference

Preclinical development of T cell receptor gene therapy

31 March 2020

1 reference

Adoptive immunotherapy of disseminated leukemia with TCR-transduced, CD8+ T cells expressing a known endogenous TCR.

31 March 2020

1 reference

Adoptive immunotherapy for indolent non-Hodgkin lymphoma and mantle cell lymphoma using genetically modified autologous CD20-specific T cells

31 March 2020

1 reference

Gene therapy with human and mouse T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigen

31 March 2020

1 reference

Tumor immunotherapy across MHC barriers using allogeneic T-cell precursors

31 March 2020

1 reference

The promise and potential pitfalls of chimeric antigen receptors

31 March 2020

1 reference

Adoptive immunotherapy: good habits instilled at youth have long-term benefits.

31 March 2020

1 reference

Restoration of immunity in lymphopenic individuals with cancer by vaccination and adoptive T-cell transfer.

31 March 2020

1 reference

Rapid immune recovery and graft-versus-host disease-like engraftment syndrome following adoptive transfer of Costimulated autologous T cells.

31 March 2020

1 reference

Increased intensity lymphodepletion and adoptive immunotherapy--how far can we go?

31 March 2020

1 reference

OX40 engagement and chemotherapy combination provides potent antitumor immunity with concomitant regulatory T cell apoptosis.

31 March 2020

1 reference

Keratinocyte growth factor enhances DNA plasmid tumor vaccine responses after murine allogeneic bone marrow transplantation.

31 March 2020

1 reference

Autoimmunity during lymphopenia: a two-hit model

31 March 2020

1 reference

Homeostasis of naive and memory T cells

31 March 2020

1 reference

Peripheral T cell survival requires continual ligation of the T cell receptor to major histocompatibility complex-encoded molecules

31 March 2020

1 reference

Control of homeostasis of CD8+ memory T cells by opposing cytokines.

31 March 2020

1 reference

Interleukin-7 mediates the homeostasis of naïve and memory CD8 T cells in vivo

31 March 2020

1 reference

Organ-specific autoimmune diseases induced in mice by elimination of T cell subset. I. Evidence for the active participation of T cells in natural self-tolerance; deficit of a T cell subset as a possible cause of autoimmune disease

31 March 2020

1 reference

Sequential expression of adhesion and costimulatory molecules in graft-versus-host disease target organs after murine bone marrow transplantation across minor histocompatibility antigen barriers

31 March 2020

1 reference

Genetics of transplantation: the major histocompatibility complex

31 March 2020

1 reference

Nobel prizes in medicine in the field of transplantation.

31 March 2020

1 reference

The National Marrow Donor Program with emphasis on the early years

31 March 2020

1 reference

Major-histocompatibility-complex class I alleles and antigens in hematopoietic-cell transplantation

31 March 2020

1 reference

The clinical significance of human leukocyte antigen (HLA) allele compatibility in patients receiving a marrow transplant from serologically HLA-A, HLA-B, and HLA-DR matched unrelated donors

31 March 2020

1 reference

National marrow donor program HLA matching guidelines for unrelated adult donor hematopoietic cell transplants

31 March 2020

1 reference

Impact of HLA class I and class II high-resolution matching on outcomes of unrelated donor bone marrow transplantation: HLA-C mismatching is associated with a strong adverse effect on transplantation outcome.

31 March 2020

1 reference

Breaking tolerance to self, circulating natural killer cells expressing inhibitory KIR for non-self HLA exhibit effector function after T cell-depleted allogeneic hematopoietic cell transplantation

31 March 2020

1 reference

Use of natural killer cells as immunotherapy for leukaemia.

31 March 2020

1 reference

Role of KIRs and KIR ligands in hematopoietic transplantation

31 March 2020

1 reference

The genetic and evolutionary balances in human NK cell receptor diversity

31 March 2020

1 reference

Toll-like receptor 4 polymorphisms and aspergillosis in stem-cell transplantation

31 March 2020

1 reference

IL2 and TNFA gene polymorphisms and the risk of graft-versus-host disease after allogeneic haematopoietic stem cell transplantation

31 March 2020

1 reference

Both donor and recipient NOD2/CARD15 mutations associate with transplant-related mortality and GvHD following allogeneic stem cell transplantation

31 March 2020

1 reference

NOD2 polymorphisms predict severe acute graft-versus-host and treatment-related mortality in T-cell-depleted haematopoietic stem cell transplantation.

31 March 2020

1 reference

Minor histocompatibility antigens as targets for immunotherapy using allogeneic immune reactions.

31 March 2020

1 reference

Tolerance to noninherited maternal antigens in mice and humans

31 March 2020

1 reference

Immunomodulation and pharmacological strategies in the treatment of graft-versus-host disease

31 March 2020

1 reference

Prophylaxis regimens for GVHD: systematic review and meta-analysis

31 March 2020

1 reference

Novel drugs for the prevention and treatment of acute GVHD.

31 March 2020

1 reference

Treatment of high-risk chronic GVHD.

31 March 2020

1 reference

Umbilical cord blood regulatory T-cell expansion and functional effects of tumor necrosis factor receptor family members OX40 and 4-1BB expressed on artificial antigen-presenting cells

31 March 2020

1 reference

Role of naturally arising regulatory T cells in hematopoietic cell transplantation

31 March 2020

1 reference

The impact of cytomegalovirus serostatus of donor and recipient before hematopoietic stem cell transplantation in the era of antiviral prophylaxis and preemptive therapy

31 March 2020

1 reference

How we treat cytomegalovirus in hematopoietic cell transplant recipients

31 March 2020

1 reference

CMV infections after hematopoietic stem cell transplantation

31 March 2020

1 reference

Clinical strategies to enhance T cell reconstitution

31 March 2020

1 reference

Adoptive precursor cell therapy to enhance immune reconstitution after hematopoietic stem cell transplantation in mouse and man.

31 March 2020

1 reference

Enhancing T cell reconstitution after hematopoietic stem cell transplantation: a brief update of the latest trends

31 March 2020

1 reference

Infusions of donor leukocytes to treat Epstein-Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation

31 March 2020

1 reference

Functionally active virus-specific T cells that target CMV, adenovirus, and EBV can be expanded from naive T-cell populations in cord blood and will target a range of viral epitopes

31 March 2020

1 reference

Monoculture-derived T lymphocytes specific for multiple viruses expand and produce clinically relevant effects in immunocompromised individuals

31 March 2020

1 reference

Antifungal therapy strategies in hematopoietic stem-cell transplant recipients: early treatment options for improving outcomes

31 March 2020

1 reference

Primary antifungal prophylaxis in hematopoietic stem cell transplant recipients: clinical implications of recent studies

31 March 2020

1 reference

Hepatic veno-occlusive disease after hematopoietic stem cell transplantation: update on defibrotide and other current investigational therapies

31 March 2020

1 reference

Hematopoietic stem cell transplantation for primary immunodeficiency disease

31 March 2020

1 reference

31 March 2020

1 reference

Blood and marrow transplantation for sickle cell disease: overcoming barriers to success

31 March 2020

1 reference

Hematopoietic cell transplantation for benign hematological disorders and solid tumors.

31 March 2020

1 reference

Haematopoietic SCT in autoimmune diseases in children: rationale and new perspectives

31 March 2020

1 reference

Hematopoietic cell transplantation for tolerance induction: animal models to clinical trials

31 March 2020

1 reference

Mesenchymal stem cells: immunobiology and role in immunomodulation and tissue regeneration

31 March 2020

1 reference

Prevention of Delayed Foreign Marrow Reaction in Lethally Irradiated Mice by Early Administration of Methotrexate

31 March 2020

1 reference

Marrow grafts between canine siblings matched by serotyping and mixed leukocyte culture

31 March 2020

1 reference

Bone-marrow transplantation in a patient with the Wiskott-Aldrich syndrome

31 March 2020

1 reference

Immunological reconstitution of sex-linked lymphopenic immunological deficiency

31 March 2020

1 reference

Reconstitution in Severe Combined Immunodeficiency by Transplantation of Marrow from an Unrelated Donor

31 March 2020

1 reference

Transplantation of marrow from an unrelated donor to a patient with acute leukemia

31 March 2020

1 reference

Cyclosporin A and methotrexate in canine marrow transplantation: engraftment, graft-versus-host disease, and induction of intolerance

31 March 2020

1 reference

Transplantation for acute leukaemia with HLA-A and B nonidentical parental marrow cells fractionated with soybean agglutinin and sheep red blood cells

31 March 2020

1 reference

Purification and characterization of mouse hematopoietic stem cells

31 March 2020

1 reference

The Nobel chronicles. 1990: Joseph Edward Murray (b 1919) and E Donnall Thomas (b 1920).

31 March 2020

1 reference

Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients

31 March 2020

1 reference

12 December 2020

Stable mixed hematopoietic chimerism in DLA-identical littermate dogs given sublethal total body irradiation before and pharmacological immunosuppression after marrow transplantation

1 reference

12 December 2020

Pathologic changes in irradiated monkeys treated with bone marrow

1 reference

12 December 2020

Engraftment of allogeneic hematopoietic progenitor cells with purine analog-containing chemotherapy: harnessing graft-versus-leukemia without myeloablative therapy

1 reference

12 December 2020

Pharmacogenetic analysis of liver toxicity after busulfan/cyclophosphamide-based allogeneic hematopoietic stem cell transplantation

1 reference

12 December 2020

Association of autoimmune disease-related gene polymorphisms with chronic graft-versus-host disease

1 reference

12 December 2020

Graft-versus-leukemia reactions after bone marrow transplantation

1 reference

12 December 2020

Allogeneic cell therapy: the treatment of choice for all hematologic malignancies relapsing post BMT

1 reference

12 December 2020

Cytolytic pathways in haematopoietic stem-cell transplantation

1 reference

12 December 2020

T-cell depletion of HLA-identical transplants in leukemia.

1 reference

12 December 2020

Transplantation for severe combined immunodeficiency with HLA-A,B,D,DR incompatible parental marrow cells fractionated by soybean agglutinin and sheep red blood cells

1 reference

12 December 2020

Genetic factors influencing irradiation protection by bone marrow. I. The F1 hybrid effect

1 reference

12 December 2020

In vitro growth of granulocytic colonies from circulating cells in human cord blood

1 reference

12 December 2020

Adoptive cell therapy for patients with metastatic melanoma: evaluation of intensive myeloablative chemoradiation preparative regimens

1 reference

12 December 2020

Modification of irradiation injury in mice and guinea pigs by bone marrow injections

1 reference

12 December 2020

NK cells in cancer immunotherapy: three decades of discovery

1 reference

12 December 2020

Transplantation potential of peripheral blood stem cells induced by granulocyte colony-stimulating factor

1 reference

12 December 2020

Cytotoxic typing antisera for marrow grafting in littermate dogs.

1 reference

12 December 2020

Plerixafor and G-CSF versus placebo and G-CSF to mobilize hematopoietic stem cells for autologous stem cell transplantation in patients with multiple myeloma

1 reference

12 December 2020

Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRC2804

1 reference

16 February 2018

PubMed ID

20168320

1 reference

16 February 2018